In cases of moderate to severe central toxicity manifesting as delirium, physostigmine may be considered, as it is a reversible cholinesterase inhibitor that crosses the blood–brain barrier and can overcome the effects of anticholinergics [64,65]. The gene discussed is BCHE; the disease is delirium.